Related references
Note: Only part of the references are listed.Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
A global survey of potential acceptance of a COVID-19 vaccine
Jeffrey V. Lazarus et al.
NATURE MEDICINE (2021)
The COVID-19 vaccines rush: participatory community engagement matters more than ever
Rochelle Ann Burgess et al.
LANCET (2021)
Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates
Molly E. Gallagher et al.
NATURE MEDICINE (2021)
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Kate M. Bubar et al.
SCIENCE (2021)
Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice
G. W. K. Moore et al.
NATURE COMMUNICATIONS (2021)
Who should be prioritized for COVID-19 vaccination in China? A descriptive study
Juan Yang et al.
BMC MEDICINE (2021)
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Olivier J. Wouters et al.
LANCET (2021)
Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
Shixiong Hu et al.
NATURE COMMUNICATIONS (2021)
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy
Piero Poletti et al.
JAMA NETWORK OPEN (2021)
Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers
Jack H. Buckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
What do we know about China's covid-19 vaccines?
Chris Baraniuk
BMJ-BRITISH MEDICAL JOURNAL (2021)
The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China
Juanjuan Zhang et al.
SCIENCE ADVANCES (2021)
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
Nawal Al Kaabi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Vaccine optimization for COVID-19: Who to vaccinate first?
Laura Matrajt et al.
SCIENCE ADVANCES (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh et al.
NATURE COMMUNICATIONS (2020)
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita et al.
SCIENTIFIC REPORTS (2020)
Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK
Christopher I. Jarvis et al.
BMC MEDICINE (2020)
Changes incontact patterns shape the dynamics of the COVID-19 outbreak in China
Juanjuan Zhang et al.
SCIENCE (2020)
Officials gird for a war on vaccine misinformation
Warren Cornwall
SCIENCE (2020)
VIEWPOINT: COVID-19 Understanding COVID-19 vaccine efficacy
Marc Lipsitch et al.
SCIENCE (2020)
Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
Wei Wang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
Anthony D. So et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Patterns of human social contact and contact with animals in Shanghai, China
Juanjuan Zhang et al.
SCIENTIFIC REPORTS (2019)
Spatial Resource Allocation for Emerging Epidemics: A Comparison of Greedy, Myopic, and Dynamic Policies
Elisa F. Long et al.
M&SOM-MANUFACTURING & SERVICE OPERATIONS MANAGEMENT (2018)
Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China
Peng Yang et al.
VACCINE (2014)